|
Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial. |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Janssen-Cilag; Sanofi |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Ipsen; Janssen-Cilag; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag |
|
|
Consulting or Advisory Role - Janssen; Novartis |
|
|
|
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi |
Speakers' Bureau - MSD Oncology |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Janssen-Cilag |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Ipsen; Janssen-Cilag; MSD Oncology; PFIZER; Roche/Genentech; Sanofi/Aventis |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis |
|
|
Consulting or Advisory Role - Astellas Oncology; BMSi; Janssen; Pfizer |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Sanofi; Steba Biotech; Takeda |
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; Janssen |
Research Funding - Ferring (Inst) |
Expert Testimony - Steba Biotech |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi |
|
|
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; janssen; Pfizer; Sanofi |
|
|
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); IPSEN (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Aventis (Inst) |
Speakers' Bureau - Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi/Aventis (Inst) |
Research Funding - BMS (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi |
|
|
No Relationships to Disclose |
|
Sophie Abadie Lacourtoisie |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Miguel Angel A. Climent Duran |
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Eisai; EUSA Pharma; Janssen Oncology; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche/Genentech; Sanofi |
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Oncology; Ipsen; Janssen; Myovant Sciences |
Consulting or Advisory Role - Astellas Oncology; Ipsen; Janssen; Myovant Sciences |
Speakers' Bureau - Astellas Oncology; Elekta; Ipsen |
Research Funding - Astellas Oncology; Ipsen; Myovant Sciences |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst) |
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer; Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Curevac; ESSA (Inst); Janssen Oncology (Inst); Orion; Sanofi (Inst) |
Travel, Accommodations, Expenses - Janssen; MSD |